VCYT
Veracyte, Inc.
Stock
$45.81+1.62 (+3.67%)Close Oct 2, 2026
- EBITDA, 2025
- $79M
- YoY, 2025
- +100.0%
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | $79M | +100.0% |
| 2024 | $40M | — |
| 2023 | −$59M | — |
| 2022 | −$15M | — |
| 2021 | −$62M | — |
| 2020 | −$27M | — |
| 2019 | −$11M | — |
| 2018 | −$18M | — |
| 2017 | −$23M | — |
| 2016 | −$25M | — |
| 2015 | −$31M | — |
| 2014 | −$28M | — |
| 2013 | −$22M | — |
| 2012 | −$18M | — |
| 2011 | −$15M | — |